Abstract:Metal ions of the later part of the first-row transition series (Fe, Co, Ni, Cu, and Zn) can form bonds through the carboxylate, hydroxyl, thiol, and imidazole side chains of proteins and those bonds are significantly more stable than formed by non-transition metals. Their adventitious binding to protein surfaces provides a great platform for maintaining the native structure of many biologically significant proteins and thus inhibiting the self-aggregation phenomenon of proteins. Aggregation followed by deposition of protein used for therapeutic purposes either at the site of administration in vivo or during storage conditions in vitro is a major concern. In this work, human insulin is induced to form 'amyloid fibrils' at acidic pH and elevated temperature and then the inhibitory activities of two transition metal ions Fe3+ and Cu2+ towards insulin amyloid fibrillation were investigated. Results show that the formation of β-sheet-rich fibrillar structure was inhibited more with Fe3+ than Cu2+-treated insulin. Dynamic light scattering and circular dichroism proved that Cu2+ was effective at lower interacting ratios with insulin, yet Fe3+ was effective in maintaining size as well as the alpha-helical conformation of monomeric insulin. This metal complex (insulin-Fe3+ or insulin-Cu2+) delayed the nucleation step of aggregation and Fe3+ is far better than Cu2+ in this endeavor. However, both of the metal ions proved their effectiveness in preventing amyloid fibrillation in vitro and can modulate the morphology of the aggregates as revealed by TEM studies. Overall the two transition metal ions Fe3+ and Cu2+ employed in this investigation are essential micronutrients too and are required in minute concentrations. The present study will encourage the applications of transition metal ions Fe3+ and Cu2+ as effective interrupters of amyloidogenesis in aggregation-prone proteins showing pathogenic amyloid deposition.

Zn-doped Cu2S quantum dots as new high-efficiency inhibitors against human insulin fibrillation based on specific electrostatic interaction with oligomers

Monitoring and Inhibition of Insulin Fibrillation by a Small Organic Fluorogen with Aggregation-Induced Emission Characteristics.

Active Site-Targeted Carbon Dots for the Inhibition of Human Insulin Fibrillation

Molecular Mechanisms of the Ultra-Strong Inhibition Effect of Oxidized Carbon Dots on Human Insulin Fibrillation.

Nontoxic Black Phosphorus Quantum Dots Inhibit Insulin Amyloid Fibrillation at an Ultralow Concentration

Bifunctional Carbon Dots for Cell Imaging and Inhibition of Human Insulin Fibrillation in the Whole Aggregation Process.

In vitro retardation and modulation of human insulin amyloid fibrillation by Fe3+ and Cu2+ ions

High-Oxygen-Content Carbon Dots As a High-Efficiency Inhibitor of Human Insulin Aggregation.

Fluorescent Silicon Nanoparticles Inhibit the Amyloid Fibrillation of Insulin

Ferrocene-modified peptides as inhibitors against insulin amyloid aggregation based on molecular simulation.

Dual Functional Amphiphilic Sugar-Coated AIE-active Fluorescent Organic Nanoparticles for the Monitoring and Inhibition of Insulin Amyloid Fibrillation Based on Carbohydrate-Protein Interactions.

Cysteine-Derived Chiral Carbon Quantum Dots: A Fibrinolytic Activity Regulator for Plasmin to Target the Human Islet Amyloid Polypeptide for Type 2 Diabetes Mellitus

Cationic molecular probes based on aggregation-induced emission for fluorescent sensing and super-resolution imaging of insulin fibrosis

Supramolecular Nanoparticles of Insulin and Pentapeptide for Inhibition of Fibrillation and Controlled Release

Inhibition mechanism of human insulin fibrillation by Bodipy carbon polymer dots and photothermal defibrillation effect of Bodipy carbon polymer dots modified by ThT

Inhibition of Insulin Fibrillation by Amphiphilic Sulfonatocalixarene

An in-depth kinetics study of chemically modified human serum albumin aggregation and fibrillation

Fluorine Functionalized Graphene Quantum Dots As Inhibitor Against Hiapp Amyloid Aggregation.

Inhibition of insulin fibrillation by osmolytes: Mechanistic Insights

Graphene Quantum Dots Against Human IAPP Aggregation and Toxicity in Vivo.

Supramolecular Nanofibers with Superior Bioactivity to Insulin-Like Growth Factor-I.